Start-Up Spotlight: Pre Diagnostics Picks Up Momentum In Early Neurodegenerative Disease Detection

Pre Diagnostics is forging ahead with plans to secure a CE mark for its PreADx immunoassay for early detection of Alzheimer’s disease. Its target for self-certification of the test under the EU IVD Directive is by the end of the second quarter.

In January, the test completed a clinical evaluation from a Norwegian multicenter trial, achieving an ROC AUC of 0.81 in distinguishing healthy controls from Alzheimer’s patients. This result, using an...